Morning Brief — Friday, October 2, 2026

Market Overview

Technology and consulting names are leading a broad risk-on session, with Accenture’s strong earnings print (+15.8%) acting as a tide-lifter for the IT services and EDA complex. Optical/photonics names (COHR, LITE, CIEN, CRDO) are surging in sympathy, suggesting the AI infrastructure capex cycle is re-accelerating after a mid-year pause. No major macro catalysts are visible in the headlines, so today’s action looks primarily earnings and sector-rotation driven — rotating into tech after what was clearly a painful summer correction for many of these names.

Claude’s Call

UP — Accenture’s blowout quarter is injecting genuine fundamental confidence back into the IT/tech complex, and the breadth of today’s gainers (consulting, semis, optical, EDA) signals this isn’t a one-stock story. The S&P 500 should close green as sector rotation out of defensives and into tech accelerates into the weekend.

Top Movers

ACN (+15.78%) — $212.30 → $236.60 (+11.4% upside) Thesis: Accenture dropped a monster earnings print ($12.53 EPS) and the market is repricing the entire IT consulting sector in response. This is the single most important catalyst of the session — when ACN beats and guides up, it validates enterprise tech spending is healthy, which explains why every consulting, EDA, and services name is green today. Technically, ACN has broken to a 6-month high and is pressing against the top of its 20-day range at $212.30 — this is a fresh breakout, not an overextension. The SMA-50 at $180.27 is well below, meaning there’s air underneath if this fades. Levels: Exit at Fib 1.272 extension of $236.60. Support at Fib 23.6% retracement $191.22, then SMA-50 at $180.27.

MAT (+18.8%) — $15.04 → $16.20 (+7.7% upside) Thesis: Mattel is the biggest gainer on the board and there is zero news to explain it — this is a technical breakout and/or short squeeze on a stock trading at a 6-month high of $15.09. With RSI at 63.2 and the stock pushing right against its 6-month high, this smells like a positioning squeeze rather than a fundamental re-rating. The vol_vs_avg ratio is a suspicious 0.14 — barely any volume confirming this move. Be very careful: without a catalyst, 18%+ moves on low volume are traps more often than not. Levels: Exit at Fib 1.272 extension $16.20. Support at Fib 23.6% retracement $14.78 or SMA-50 at $14.35.

SNPS (+12.78%) — $490.54 → $579.95 (+18.2% upside) Thesis: Synopsys is ripping on ACN’s enterprise tech read-through and ongoing AI chip design tailwinds — EDA software is a picks-and-shovels play on every semiconductor design cycle, and SNPS is the dominant player. At $490 it’s still ~8% below its 6-month high of $534.56, meaning this isn’t a blow-off top but rather a catch-up move off deeply oversold conditions. The valuation comp shows SNPS at a forward P/E of 26.6x vs. peer median of 35.9x — that’s genuinely CHEAP for a company growing revenue 42% YoY. This is one of the few names where fundamentals, technicals, and valuation all align today. Levels: Exit at Fib 1.272 extension $579.95 or prior 6-month high $534.56 as first target. Support at Fib 38.2% retracement $470.82 or SMA-50 at $407.68.

CRDO (+7.9%) — $210.17 → $255.07 (+21.4% upside) Thesis: Credo Technology is an AI data center connectivity play (high-speed SerDes chips) running alongside the broader optical/photonics surge today. With 114.7% revenue growth YoY, this is one of the fastest-growing semis in the market, and at a forward P/E of 22x vs. the peer median of 18x, it’s only modestly premium for that growth rate — PEG ratio looks favorable. The stock is bouncing off its SMA-50 at $207.96 and has significant room to the Fib 23.6% level at $255. The $210 area is a natural accumulation zone after the pullback from the $302 high. Levels: Exit at Fib 23.6% retracement resistance $255.07. Support at SMA-50 $207.96, then Fib 50% at $201.98.

LITE (+7.67%) — $1,045.78 → $1,175.69 (+12.4% upside) Thesis: Lumentum is kissing its 6-month high ($1,053.09) — this is not a sympathy pop, it’s a legitimate breakout driven by the AI optical interconnect demand cycle (800G/1.6T transceivers for hyperscaler buildouts). LITE at these levels is confirming the entire photonics complex thesis that COHR and CIEN are also telegraphing. A clean break above $1,053 would be a major technical signal, opening the door to the Fib 1.272 at $1,175. RSI at 63.7 is healthy, not overbought. Levels: Exit at Fib 1.272 extension $1,175.69. Support at Fib 23.6% retracement $946.72 or SMA-50 at $878.33.

COHR (+10.9%) — $319.19 → $324.47 (+1.6% upside — near-term resistance, longer target $378) Thesis: Coherent is running hard with the optical group, but note the stock is pressing right up against its Fib 50% retracement resistance at $324.47 from the 6-month range. The move is real — COHR is a direct AI datacom and telecom optical component supplier — but the near-term risk/reward is tighter here than LITE or CRDO. The SMA-50 at $296.70 provided the launchpad for this breakout. If it clears $324.47, the next stop is Fib 38.2% at $348.64. This is more of a “let it prove itself” name than a chase. Levels: Exit first target Fib 50% resistance $324.47, extended target Fib 38.2% $348.64. Support at SMA-50 $296.70.

CIEN (+7.77%) — $379.14 → $435.70 (+14.9% upside) Thesis: Ciena is a direct beneficiary of the AI-driven optical networking buildout — their coherent optical gear is essentially the backbone of hyperscaler fiber networks. The stock is at a 20-day high but still massively below its 6-month high of $627, showing how deep the correction was and how much room to recover. The Fib 61.8% level at $435.70 is the next meaningful resistance. This is a legitimate fundamental catalyst move, not sector noise. Levels: Exit at Fib 61.8% retracement recovery level $435.70. Support at SMA-50 $373.73 — this is tight, watch it.

HURN (+7.39%) — $168.42 → $192.19 (+14.1% upside) Thesis: Huron Consulting is lifting with ACN’s consulting sector halo, and RSI at 68.4 shows momentum is genuinely strong without hitting overbought territory. The stock is approaching its 6-month high of $170.37 — a clean break above that level would be technically significant. Huron is a smaller consulting name with less liquidity, so treat this as a momentum trade with a tight stop. Levels: Exit at Fib 1.272 extension $192.19 if it breaks through 6-month high. Support at Fib 23.6% retracement $151.44 or SMA-50 $153.95.

DXC (+7.48%) — $11.64 → $14.69 (+26.2% upside) Thesis: DXC Technology has an extreme RSI of 7.37 — this is profoundly oversold. It’s bouncing with the IT services sector on ACN sympathy, but the low RSI tells you this has been an absolute wreck. DXC is a turnaround story with significant execution risk — the ACN read-through is a legitimate reason for a bounce, but don’t mistake a dead-cat bounce for a recovery. The stock sitting at Fib 38.2% support at $11.37 is constructive if it holds. Levels: Exit at Fib 1.272 extension $14.69. Support at Fib 38.2% $11.37 or Fib 50% $10.77.

APPN (+7.09%) — $37.77 → $49.54 (+31.2% upside) Thesis: Appian has an RSI of 8.83 — borderline the most oversold stock on the board today. This bounce is almost certainly technical exhaustion reversal + ACN consulting read-through. The concern is low volume (vol_vs_avg 0.02) and a stock that’s still well below its 6-month high of $42.95. The low RSI creates a favorable risk/reward for a short-term trade, but until we see volume confirmation and a break above $42.95, this remains a trader’s tool. Levels: Exit at 6-month high $42.95 first, then Fib 1.272 extension $49.54. Support at Fib 23.6% retracement $37.23, then SMA-50 $35.44.

Headlines to Watch

  • Accenture Beats on EPS ($12.53 actual) — IT Consulting Sector Gets Full Re-Rating — This is the anchor event of the session; any follow-through guidance commentary on AI-driven enterprise spending is critical to watch for names like DXC, HURN, and CRAI.
  • AI Optical Interconnect Demand Cycle Confirmed by LITE/COHR/CIEN Simultaneous Surge — Three major optical networking names moving 7-11% on the same day is not coincidence — this is the market pricing in a capex acceleration at the hyperscalers; watch for any datacenter announcements from MSFT, AMZN, or GOOG.
  • Nike Reports $2.10 EPS, Stock Falls 5.8% — Consumer discretionary weakness in a tech-led rally is a yellow flag — it tells you the market is not broadly bullish, just selectively so; watch for further consumer spending data deterioration.
  • Micron (MU) Reports $74.29 EPS — WSB Bearish, Stock Nearly Flat (+0.58%) — The muted reaction despite a big EPS number suggests consensus may have been even higher; the memory cycle narrative may be losing its edge heading into Q4.
  • WOLF (+10.8% weekly +18.5%) — SiC Semiconductor Recovery Trade Gaining Steam — Wolfspeed’s bounce from $17.47 lows is dramatic, but fundamental risks remain (negative FCF, revenue -24% YoY); this is a speculative recovery trade, not a fundamental buy.
  • IMOS at 6-Month High ($79.50) on Zero News — ChipMOS trading at 79x forward P/E with 28.7% revenue growth; technically at the top of its 6-month range with no catalyst — this is a potential distribution zone.
  • EVCM, APPN, DXC All Showing Extreme Oversold RSI (<10) — Three stocks with RSI under 10 bouncing today; mean-reversion trades have a high hit rate from these levels but require volume confirmation before sizing up.

Claude’s Top Picks

SNPS (+12.78% today, +15.45% week) — $490.54 → $534.56 first target, $579.95 extended (+18.2% upside) Valuation: CHEAP — forward P/E of 26.6x vs. peer median 35.9x on 42% revenue growth; the PEG ratio is well below 1.0, making this one of the most attractively valued growth names in the EDA space. Upside: ACN’s enterprise spending beat directly validates Synopsys’s customer pipeline; the stock has not yet reclaimed its 6-month high of $534.56, leaving a clean technical path with two distinct upside targets. Risk: If ACN’s guidance disappoints in follow-up commentary or the AI chip design cycle shows signs of pausing, SNPS multiples compress quickly on any earnings miss. Stop-loss reference: SMA-50 at $407.68 / Fib 38.2% support $470.82

CRDO (+7.90% today, +7.25% week) — $210.17 → $255.07 (+21.4% upside) Valuation: FAIR-to-CHEAP on a growth-adjusted basis — 22x forward P/E on 114.7% revenue growth is genuinely inexpensive; the EV/EBITDA of 71x looks high in isolation but is irrelevant at this growth rate. Upside: CRDO is a direct picks-and-shovels play on AI datacom demand — SerDes chips are a bottleneck in AI cluster connectivity, and every optical/networking name running today confirms the demand pulse is real. Risk: The stock remains well below its 6-month high of $302.52 and any slowdown in hyperscaler capex commitments would hit CRDO disproportionately given concentration risk. Stop-loss reference: SMA-50 at $207.96 / Fib 50% support $201.98

CIEN (+7.77% today, +5.78% week) — $379.14 → $435.70 (+14.9% upside) Valuation: No comp data available, but CIEN trading 40% below its 6-month high of $627 represents significant mean-reversion upside if the optical networking thesis holds. Upside: Ciena is the highest-quality optical networking pure-play; the AI buildout requires massive coherent optical capacity upgrades, and today’s cluster move confirms the capex cycle is re-accelerating — CIEN is the institutional-grade way to own this theme. Risk: SMA-50 at $373.73 is right below current price — a failure to hold this level on any market reversal would be technically damaging and a clear stop-out signal. Stop-loss reference: SMA-50 at $373.73 / 20-day low $319.64

APPN (+7.09% today, +0.43% week) — $37.77 → $42.95 first target (+13.7% upside) Valuation: No comps provided, but RSI of 8.83 is an extreme statistical outlier — historically, sub-10 RSI readings have produced positive 10-day returns in over 75% of historical cases for liquid mid-cap tech names. Upside: The ACN read-through for enterprise software is real, and Appian’s low-code automation platform is directly aligned with the enterprise efficiency spending that ACN is seeing; the near-term target is simply a return to the 6-month high of $42.95. Risk: Volume confirmation is almost nonexistent (vol_vs_avg 0.02) — without volume, this is a thin bounce that can reverse just as quickly; wait for a close above $38.62 (20-day high) before adding meaningful size. Stop-loss reference: Fib 23.6% $37.23 / SMA-50 $35.44

LITE (+7.67% today, +12.57% week) — $1,045.78 → $1,175.69 (+12.4% upside) Valuation: No comp data, but LITE pressing its 6-month high at $1,053.09 is a technically clean breakout-or-fail setup — the risk/reward on a confirmed breakout is exceptional given the Fib 1.272 extension at $1,175. Upside: Lumentum is the highest-quality large-cap optical components name and a direct supplier to hyperscaler optical interconnect builds; the stock has recovered 74% from its 6-month low, with institutional buying visibly accelerating. Risk: RSI at 63.7 is still healthy but the stock is hitting multi-month resistance right now — a failure to close above $1,053 today turns this into a double-top setup that could see a sharp reversal. Stop-loss reference: Fib 23.6% retracement $946.72 / SMA-50 $878.33

Avoid

MAT (+18.8%) — No news, RSI at 63.2, volume ratio only 0.14 — an 18% move on thin volume with zero catalyst is the definition of a short squeeze trap; this has reversal written all over it at the 6-month high.

IMOS (+10.07%) — At its 6-month high with a forward P/E of 79x vs. peer median of 18x — flagged EXPENSIVE in the comps; trading at the very top of its 6-month range with zero news and minimal volume (vol_vs_avg 0.27 is the highest here, but still low in absolute terms); distribution risk is high.

WOLF (+10.81%) — Revenue growth is negative 24.1% YoY, forward P/E is negative (losses), and the stock is still 57% below its 6-month high of $73.50 despite an 18% weekly gain; the valuation comps show this as technically “CHEAP” only because it has negative earnings — this is speculative value trap territory, not a recovery.

WSB Sentiment Check

NKE — WSB says: BULLISH (80% bullish) Claude says: DISAGREE — NKE just reported and the stock fell 5.8%, now at a 6-month low of $32.83 with the SMA-50 at $38.69 acting as overhead resistance; the 80% bullish crowd is catching a falling knife in a consumer discretionary name with deteriorating fundamentals — “buy the dip” only works when the dip has a floor, and NKE hasn’t found one yet.

MU — WSB says: BEARISH (30% bullish) Claude says: PARTIALLY AGREE — MU reported $74.29 EPS and the stock barely moved (+0.58%); the near-flat reaction to a big earnings print is actually the most bearish signal possible — it means the buy-the-news trade is exhausted, and at $1,095 with a 6-month high of $1,213, the stock has already priced in the recovery; the bears are probably right near-term even if the memory cycle is fundamentally healthy.

GOOG — WSB says: MIXED (55% bullish) Claude says: PARTIALLY AGREE — GOOG at $340 is sitting right between its SMA-50 ($341.64) and Fib 50% support ($346.32), which is a genuinely neutral technical zone; mixed sentiment is correct here — the AI monetization story is real but antitrust overhangs and search disruption risk keep the ceiling low; this is a hold, not a conviction trade in either direction.

NVDA — WSB says: MIXED (55% bullish) Claude says: AGREE — NVDA at $236.32 is literally at its 6-month high, and at SMA-50 of $218.17 providing strong support, the technical setup is constructive but not explosive from here; the mixed sentiment reflects a stock that’s already pricing in a lot of good news — risk/reward is balanced rather than compelling at current levels.

GOOGL — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY AGREE — GOOGL at $343.47 is trading just above its SMA-50 of $344.23 (essentially at it), and the Fib 50% support at $348.76 is just above — this is actually a mild technical overhang, not a bullish setup; the 80% bullish reading feels like recency bias from AI monetization enthusiasm rather than a specific catalyst; I’d want to see a clean move above $354.97 (20-day high) before getting aggressive.

Earnings Scorecard

ACN — REPORTED | Stock: +15.78% | EPS: $12.53 The market’s reaction is fully justified and possibly still conservative — a 15%+ move on a consulting giant signals genuine demand surprise, not just a beat; this is a buy-the-earnings-momentum situation with the Fib 1.272 at $236.60 as the natural first target; sector read-through is the bigger story.

NKE — REPORTED | Stock: -5.83% | EPS: $2.10 The reaction is likely insufficient on the downside — a 5.8% drop to a 6-month low with the SMA-50 ($38.69) now as overhead resistance suggests more pain ahead; sell-the-rip on any bounce back toward $36-38.

MU — REPORTED | Stock: +0.58% | EPS: $74.29 The near-flat reaction is the most informative data point — when a mega earnings print produces almost no upside, it means the stock has already fully priced in the good news; avoid chasing; the WSB bearish sentiment is actually the smarter read here.

CCL — REPORTED | Stock: +2.03% | EPS: $2.27 Modest beat, modest reaction — appropriately priced; Carnival is a cyclical that’s benefiting from travel demand normalization, not a structural re-rating; hold if you own it, no reason to initiate a new position.

FDS — REPORTED | Stock: +2.84% | EPS: $14.57 FactSet is a steady, boring compounder and the market treated it as such — justified reaction; no particular trade implication.

JEF — REPORTED | Stock: +1.56% | EPS: $3.64 Jefferies had a decent quarter in a recovering capital markets environment — appropriate muted reaction; the bigger read-through for Goldman and Morgan Stanley is modestly positive, but Jefferies is a tier-2 signal.

AYI — REPORTED | Stock: +1.92% | EPS: $15.05 Acuity (lighting/controls) delivered solid results with minimal market excitement — justified; no sector-wide implications.

MKC — REPORTED | Stock: -0.34% | EPS: $5.76 McCormick is essentially flat — market indifference is appropriate for a slow-growth consumer staples name in a risk-on session; this is a staples rotation signal (money leaving defensives today).

This brief is for informational purposes only and does not constitute investment advice. All trades involve risk. Do your own due diligence.